Valuation: Universe Pharmaceuticals INC

Market Cap 23.87M 20.79M 19.67M 17.87M 33.39M 2.29B 33.56M 234M 90.61M 1.16B 89.65M 87.66M 3.72B P/E 2024
-0.23x
P/E 2025 -0.52x
Enterprise Value -469K -409K -387K -351K -657K -44.94M -660K -4.61M -1.78M -22.84M -1.76M -1.72M -73.11M EV / Sales 2024
-0.68x
EV / Sales 2025 -1.23x
Free-Float
11.18%
Yield 2024 *
-
Yield 2025 -
1 day-0.21%
1 week+22.42%
Current month+3.71%
1 month-17.82%
3 months+63.23%
6 months+79.25%
Current year+24.67%
1 week 4.27
Extreme 4.27
4.83
1 month 3.77
Extreme 3.7701
5.91
Current year 2
Extreme 2
17.96
1 year 2
Extreme 2
17.96
3 years 2
Extreme 2
2,592
5 years 2
Extreme 2
9,612.71
10 years 2
Extreme 2
43,163.97
Manager TitleAgeSince
Chief Executive Officer 58 -
Director of Finance/CFO 50 -
Chief Operating Officer 46 01/12/2021
Director TitleAgeSince
Chairman 58 -
Director/Board Member 50 -
Director/Board Member 59 01/03/2021
Change 5-day change 1-year change 3-year change Capi.($)
-0.21%+22.42%+9.20%-99.46% 23.92M
+1.08%+1.96%-12.85%-3.91% 13.52B
+0.26%-2.03%-33.85%-56.71% 4.74B
-0.93%-1.19%-4.30%-6.33% 4.38B
-0.40%-1.95%-10.11%-32.47% 3.78B
-0.87%-1.41%-1.99%-4.01% 3.49B
-0.21%-2.77%-23.40%-2.35% 3.4B
+0.22%-1.41%-12.38%-1.83% 3.1B
-0.61%-0.20%-22.56%-18.19% 2.31B
+0.31%-2.48%-29.67%-22.02% 1.62B
Average -0.14%+1.45%-14.19%-24.73% 4.04B
Weighted average by Cap. +0.16%+0.48%-15.27%-14.36%

Financials

2024 2025
Net sales 23.02M 20.05M 18.98M 17.24M 32.22M 2.21B 32.37M 226M 87.41M 1.12B 86.49M 84.57M 3.59B 17.86M 15.55M 14.72M 13.38M 24.99M 1.71B 25.11M 175M 67.8M 869M 67.09M 65.6M 2.78B
Net income -8.73M -7.6M -7.19M -6.54M -12.21M -836M -12.27M -85.69M -33.13M -425M -32.78M -32.06M -1.36B -3.67M -3.2M -3.03M -2.75M -5.14M -352M -5.16M -36.05M -13.94M -179M -13.79M -13.49M -572M
Net Debt -21.5M -18.73M -17.73M -16.11M -30.09M -2.06B -30.24M -211M -81.64M -1.05B -80.78M -78.98M -3.35B -24.34M -21.2M -20.06M -18.23M -34.05M -2.33B -34.22M -239M -92.39M -1.18B -91.42M -89.38M -3.79B
Logo Universe Pharmaceuticals INC
Universe Pharmaceuticals Inc is a holding company primarily engaged in the manufacturing, marketing, sales and distribution of traditional Chinese medicine drugs (TCMDs) products targeting the elderly. The Company’s products include chronic condition treatments and cold and flu medicines. The chronic condition treatments primarily include Guben Yanling Pill, Shenrong Weisheng Pill, Quanlu Pill, Yangxue Danggui Syrup, Wuzi Yanzong Oral Liquid, Fengtong Medicinal Liquor, Shenrong Medicinal Liquor, Qishe Medicinal Liquor, Fengshitong Medicinal Liquor, and Shiquan Dabu Medicinal Liquor. The cold and flu medicines primarily include Paracetamol Granule for children, Isatis Root Granule and Qiangli Pipa Syrup. The Company is also engaged in the sales of biomedical drugs medical instruments, Traditional Chinese Medicine Pieces (TCMPs), and dietary supplements manufactured by third-party pharmaceutical companies.
Employees
-
Date Price Change Volume
17/09/26 $4.750 -0.21% 17,160
16/09/26 $4.760 +6.73% 41,126
15/09/26 $4.460 -7.28% 60,142
14/09/26 $4.810 +10.32% 173,282
11/09/26 $4.360 +12.37% 145,185
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!